PROMOVIA®

*all content is intended for healthcare professionals.
Request info

PROMOVIA® 2 24 mg/2mL

Concentration of the formulation: 1,2 % of Sodium Hyaluronate

Syringe Volume: 2 mL

Administration cycle: 3 to 5 injections (under medical advice)

Internal leaflet MDR EU 745/2017
Summary of safety and clinical performance
Request info

PROMOVIA® 2 40 mg/2mL

Concentration of the formulation: 2,0% of Sodium Hyaluronate

Syringe Volume: 2 mL

Administration cycle: 3 injections (under medical advice)

Internal leaflet MDR EU 745/2017
Summary of safety and clinical performance
Request info

PROMOVIA® 4 60 mg/4mL

Concentration of the formulation: 1,5 % of Sodium Hyaluronate

Syringe Volume: 4 mL

Administration cycle: 1-2 injections (under medical advice)

Internal leaflet MDR EU 745/2017
Summary of safety and clinical performance
Request info

PROMOVIA® 4 80 mg/4mL

Concentration of the formulation: 2,0% of Sodium Hyaluronate

Syringe Volume: 4 mL

Administration cycle: 1 injection (under medical advice)

Internal leaflet MDR EU 745/2017
Summary of safety and clinical performance

CONTACTS

Innate S.r.l.
Tel. +39 01432645
info@innate.it
Viale Industria 11-13
15067 Novi ligure (AL) Italy

Via Nerviano, 31
20045 Lainate (MI) Italy

* All fields are mandatory

    Name and Surname *
    Email address *
    Country *
    Company
    Request *
    I authorize the processing of my personal data to be updated on new arrivals and for direct marketing purposes related to the services offered